Variation in the use of neoadjuvant chemotherapy for breast cancer in the Netherlands: a lack of consensus

P.E.R. Spronk, A.C.M. van Bommel, Sabine Siesling, M.J. Vrancken Peeters, C.M. Smorenburg

Research output: Contribution to conferenceAbstract

215 Downloads (Pure)

Abstract


Original languageEnglish
Number of pages1
Publication statusPublished - Dec 2016
Event39th Annual CTRC-AACR San Antonio Breast Cancer Symposium, SABCS 2016 - San Antonio, United States
Duration: 6 Dec 201610 Dec 2016
Conference number: 39

Conference

Conference39th Annual CTRC-AACR San Antonio Breast Cancer Symposium, SABCS 2016
Abbreviated titleSABCS
CountryUnited States
CitySan Antonio
Period6/12/1610/12/16

    Fingerprint

Keywords

  • 10-year disease-free survival
  • breast cancer
  • breast-conserving surgery
  • radiation therapy
  • time interval

Cite this

Spronk, P. E. R., van Bommel, A. C. M., Siesling, S., Vrancken Peeters, M. J., & Smorenburg, C. M. (2016). Variation in the use of neoadjuvant chemotherapy for breast cancer in the Netherlands: a lack of consensus. Abstract from 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium, SABCS 2016, San Antonio, United States.